Pregabalin dependence, withdrawal, suicidality and psychosis reports: A disproportionality analysis of the Australian adverse events database
Adverse events related to drug dependence and psychosis are reported to the Australian pharmacovigilance database at a higher rate for pregabalin compared to other drugs, including other neuropathic pain drugs, signalling a potential concern that warrants further investigation.
Authors
- Suzanne Nielsen (ORCID: https://orcid.org/0000-0001-5341-1055)
- Claire E. Ashton‐James (ORCID: https://orcid.org/0000-0001-5547-4295)
- Amy G. McNeilage (ORCID: https://orcid.org/0000-0001-7112-042X)
- Ali Gholamrezaei (ORCID: https://orcid.org/0000-0001-8674-450X)
- Bridin Murnion (ORCID: https://orcid.org/0000-0001-7791-3025)
Institutions
- The University of Sydney (AU)
- UNSW Sydney (AU)
- St Vincent's Health (AU)
- Eastern Health (AU)
- Monash Health (AU)
- St Vincent's Clinic (AU)
- Monash University (AU)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1002/bcp.70279
- Citations
- 2
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 2.61
Funders
- Australian Government
- University of Sydney
- National Health and Medical Research Council